EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:135193 - fospropofol
| Formula | C13H21O5P |
| Net Charge | 0 |
| Average Mass | 288.280 |
| Monoisotopic Mass | 288.11266 |
| SMILES | CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O |
| InChI | InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) |
| InChIKey | QVNNONOFASOXQV-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiviral agent A substance that destroys or inhibits replication of viruses. anti-obesity agent Any substance which is used to reduce or control weight. |
| Applications: | hepatoprotective agent Any compound that is able to prevent damage to the liver. anti-inflammatory agent Any compound that has anti-inflammatory effects. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. vulnerary A drug used in treating and healing of wounds. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fospropofol (CHEBI:135193) has role analgesic (CHEBI:35480) |
| fospropofol (CHEBI:135193) has role anti-arrhythmia drug (CHEBI:38070) |
| fospropofol (CHEBI:135193) has role anti-inflammatory agent (CHEBI:67079) |
| fospropofol (CHEBI:135193) has role anti-obesity agent (CHEBI:74518) |
| fospropofol (CHEBI:135193) has role antidepressant (CHEBI:35469) |
| fospropofol (CHEBI:135193) has role antihypertensive agent (CHEBI:35674) |
| fospropofol (CHEBI:135193) has role antineoplastic agent (CHEBI:35610) |
| fospropofol (CHEBI:135193) has role antiviral agent (CHEBI:22587) |
| fospropofol (CHEBI:135193) has role cardiovascular drug (CHEBI:35554) |
| fospropofol (CHEBI:135193) has role hepatoprotective agent (CHEBI:62868) |
| fospropofol (CHEBI:135193) has role neuroprotective agent (CHEBI:63726) |
| fospropofol (CHEBI:135193) has role vulnerary (CHEBI:73336) |
| fospropofol (CHEBI:135193) is a alkylbenzene (CHEBI:38976) |
| INN | Source |
|---|---|
| fospropofol | WHO MedNet |
| Synonyms | Source |
|---|---|
| fospropofol disodium | DrugCentral |
| fospropofol sodium | DrugCentral |
| lusedra | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| 3249 | DrugCentral |
| HMDB0015661 | HMDB |
| Registry Numbers | Sources |
|---|---|
| CAS:258516-89-1 | DrugCentral |
| Citations |
|---|